This seems misleading at best Goodfella.
Bad debts are trending downwards (see the arrears), and group bad debts are staying the same. It's been shown as a percentage of TTV for a long time, and that's how it should be shown. All stats should be in relation to the TTV for consistency.
Customer growth in terms of actual customers are only stagnant because they are trying to keep bad debts down - and I see you made no mention to the massive customer growth in terms of revenue, number of transactions and TTV particularly for the US that is only going to continue to grow quickly.
As interest rates drop the bad debts will get further under control, and their funding costs will decrease, and margins will skyrocket.
They are cash flow positive now, and as they continue to scale the profits will come.
And nothing they released early contradicted what was released in the half yearly report - if anything the half yearly report was better than I expected.
- Forums
- ASX - By Stock
- ZIP
- Ann: Half Yearly Report and Accounts
ZIP
zip co limited..
Add to My Watchlist
2.71%
!
$3.03

Ann: Half Yearly Report and Accounts, page-132
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.03 |
Change
0.080(2.71%) |
Mkt cap ! $3.921B |
Open | High | Low | Value | Volume |
$2.98 | $3.05 | $2.92 | $73.33M | 24.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 152664 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 126882 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18000 | 3.020 |
1 | 5600 | 3.010 |
3 | 30537 | 3.000 |
2 | 10170 | 2.990 |
1 | 33553 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.030 | 2500 | 1 |
3.050 | 40386 | 17 |
3.060 | 29688 | 7 |
3.070 | 16200 | 5 |
3.080 | 130900 | 6 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online